Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMDP) Enterprise Value (2016 - 2025)

Historic Enterprise Value for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to -$22.1 million.

  • LifeMD's Enterprise Value rose 3849.37% to -$22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.1 million, marking a year-over-year increase of 3849.37%. This contributed to the annual value of -$33.5 million for FY2024, which is 616.02% down from last year.
  • As of Q3 2025, LifeMD's Enterprise Value stood at -$22.1 million, which was up 3849.37% from -$34.3 million recorded in Q2 2025.
  • LifeMD's Enterprise Value's 5-year high stood at -$4.6 million during Q4 2022, with a 5-year trough of -$42.6 million in Q4 2021.
  • Over the past 5 years, LifeMD's median Enterprise Value value was -$22.1 million (recorded in 2025), while the average stood at -$22.9 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 235945.32% in 2021, then skyrocketed by 8928.25% in 2022.
  • Over the past 5 years, LifeMD's Enterprise Value (Quarter) stood at -$42.6 million in 2021, then soared by 89.28% to -$4.6 million in 2022, then crashed by 592.1% to -$31.6 million in 2023, then decreased by 6.16% to -$33.5 million in 2024, then soared by 34.01% to -$22.1 million in 2025.
  • Its Enterprise Value was -$22.1 million in Q3 2025, compared to -$34.3 million in Q2 2025 and -$32.7 million in Q1 2025.